Edward Man-Lik Choi

6PUBLICATIONS
33CO-AUTHORS
Medical infection agents (incl. prions)Serious gamesPanel data analysisEpidemiological modellingMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 07, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Christina Dold, Blanché Oguti, Laura Silva-Reyes

|May 02, 2025
Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the Congo.

Hannah E Brindle, Darius Tetsa-Tata, Tansy Edwards

|Aug 29, 2024
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.

Edward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo

|Aug 29, 2024
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo.

Hugo Kavunga-Membo, Deborah Watson-Jones, Kambale Kasonia

|Mar 09, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.

Deborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais

|Mar 18, 2021
COVID-19 vaccines for low- and middle-income countries.

Edward M Choi

Pageof 1

Frequent Collaborators

3 joint publications

Deborah Watson-Jones

3 joint publications

Tansy Edwards

3 joint publications

Kambale Kasonia

2 joint publications

Babajide Keshinro